Infectious Diseases (except HIV/AIDS)

RGFSAMNet: An interpretable COVID-19 detection and classification by using the deep residual network with global feature fusion and attention mechanism
S M Rakib Ul Karim, Diponkor Bala, Rownak Ara Rasul, Sean Goggins

medRxiv 2024.10.30.24316451; doi: https://doi.org/10.1101/2024.10.30.24316451

Add to Selected Citations
When is the R = 1 epidemic threshold meaningful?
Kris V Parag, Anne Cori, Uri Obolski

medRxiv 2024.10.28.24316306; doi: https://doi.org/10.1101/2024.10.28.24316306

Add to Selected Citations
Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: primary day-28 analysis of a phase 2/3 open-label study
Katia Alves, Alex Kouassi, Joyce S. Plested, Raj Kalkeri, Katherine Smith, Muneer Kaba, Joy Nelson, Mingzhu Zhu, Shane Cloney-Clark, Zhaohui Cai, Raburn M. Mallory, Fernando Noriega

medRxiv 2024.10.25.24316129; doi: https://doi.org/10.1101/2024.10.25.24316129

Add to Selected Citations
Long-Term Impact of Molecular Epidemiology Shifts of Methicillin-resistant Staphylococcus aureus on Severity and Mortality of Bloodstream Infection
Norihito Kaku, Masaki Ishige, Go Yasutake, Daisuke Sasaki, Kenji Ota, Fujiko Mitsumoto-Kaseida, Kosuke Kosai, Hiroo Hasegawa, Koichi Izumikawa, Hiroshi Mukae, Katsunori Yanagihara

medRxiv 2024.02.15.24302553; doi: https://doi.org/10.1101/2024.02.15.24302553

Add to Selected Citations
Xpert MTB/RIF Ultra resistant and MTBDRplus susceptible rifampicin results in people with tuberculosis: utility of FluoroType MTBDR and deep sequencing
Yonas Ghebrekristos, Aysha Ahmed, Natalie Beylis, Sarishna Singh, Christoffel Opperman, Fahd Naufal, Megan Folkerts, David Engelthaler, Erick Auma, Rouxjeane Venter, Ghowa Booley, John Metcalfe, Robin Warren, Grant Theron

medRxiv 2024.10.25.24316070; doi: https://doi.org/10.1101/2024.10.25.24316070

Add to Selected Citations
A systematised review of seasonal influenza case-fatality risk
Johnny A N Filipe, Carlos K H Wong, Edwin van Leeuwen, Lucy Goodfellow, Simon R Procter, Mark Jit

medRxiv 2024.10.22.24315943; doi: https://doi.org/10.1101/2024.10.22.24315943

Add to Selected Citations
Adaptive behavior in response to the 2022 mpox epidemic in the Paris region
Davide Maniscalco, Olivier Robineau, Pierre-Yves Boëlle, Mattia Mazzoli, Anne-Sophie Barret, Emilie Chazelle, Alexandra Mailles, Harold Noël, Arnaud Tarantola, Annie Velter, Laura Zanetti, Vittoria Colizza

medRxiv 2024.10.25.24315987; doi: https://doi.org/10.1101/2024.10.25.24315987

Add to Selected Citations
Symptom burden, viral load, and antibody response to ancestral SARS-CoV-2 strain [D614G] in an outpatient household cohort
Mehal Churiwal, Kathleen Tompkins, Gabrielle Streeter, Christy Litel, Sydney Mason, Kelly Lin, Meredith Muller, Srijana Chhetri, Tia Belvin, Christopher Basham, Maureen Whittelsey, Tyler Rapp, Lakshmanane Premkumar, Carla Cerami, Jessica T. Lin

medRxiv 2024.10.27.24316219; doi: https://doi.org/10.1101/2024.10.27.24316219

Add to Selected Citations
Clinical evolution and medical resource utilization in adult patients with respiratory syncytial virus infection at a community hospital in Argentina
Agustin Bengolea, Juan I Ruiz, Celina G. Vega, Matias Manzotti, Nadia Zuccarino, Lucila Rey Ares

medRxiv 2024.10.27.24316220; doi: https://doi.org/10.1101/2024.10.27.24316220

Add to Selected Citations
Evaluation of current practice of antimicrobial use and clinical outcome in the management of children with pneumonia admitted to Jimma Medical Center, Southwest Ethiopia: A prospective observational study
Abduba Wariyo Guyo, Berhanu Teshome Derese

medRxiv 2024.10.26.24316179; doi: https://doi.org/10.1101/2024.10.26.24316179

Add to Selected Citations

Infectious Diseases (except HIV/AIDS)

Pages